The human HNP36 gene is localized to chromosome 11q13 and produces alternative transcripts that are not mutated in multiple endocrine neoplasia, type 1 (MEN I) syndrome

Genomics

Volumn 42, Issue 2, 1997, Pages 325-330

  Williams, John B ^a,b,c   Rexer, Brent ^a   Sirripurapu, Sarada ^a   John, Sutha ^a   Goldstein, Richard ^a,b,c   Phillips III, John A ^a,b   Haley, Linda L ^d   Sait, Shiela N J ^d   Shows, Thomas B ^d   Smith, Carissa M ^e   Gerhard, Daniela S ^e  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d ROSWELL PARK CANCER INSTITUTE   (United States)

^e WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11Q; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; MULTIPLE ENDOCRINE NEOPLASIA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING;

EID: 0031172377     PISSN: 08887543     EISSN: None     Source Type: Journal    
DOI: 10.1006/geno.1997.4751     Document Type: Article

References (37)

1. Bale, A. E., Norton, J. A., Wong, E. L., Fryburg, J. S., Maton, P. N., Oldfield, E. H., Streeten, E., Aurbach, G. D., Brandi, M. L., Friedman, E., et al. (1990). Allelic loss on chromosome 11 in hereditary and sporadic tumors related to familial multiple endocrine neoplasia syndrome type 1. Cancer Res. 51: 1154-1157.
2. Barker, H. M., Jones, T. A., da Cruz e Silva, E. F., Spurr, N. K., Sheer, D., and Cohen, P. T. (1990). Localization of the gene encoding a type 1 protein phosphatase catalytic subunit to human chromosome band 11q13. Genomics 7: 159-166.
3. Brison, O. (1993). Gene amplification and tumor progression. Biochim. Biophys. Acta 1155: 25-41.
4. Bystrom, C. C., Larsson, C., Blomberg, C., Sandelin, K., Falkmer, U., Skogseid, B., Oberg, K., Werner, S., and Nordenskjold, M. (1990). Localization of the MEN 1 gene to a small region within chromosome band 11q13 by deletion mapping in tumors. Proc. Natl. Acad. Sci. USA 87: 1968-1972.
5. Campuzano, V., Montermini, L., Molto, M. D., Pianese, L., Cossee, M., Cavalcanti, F., Monros, E., Rodius, F., Duclos, F., Monticelli, A., et al. (1996). Friedreich's ataxia: Autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science 271: 1423-1427.
6. Carling, T., Rastad, J., Ridefelt, P., Gobi, A., Hellman, P., Oberg, K., Rask, L., Larsson, C., Juhlin, C., Akerstrom, G., and Skogseid, B. (1995). Hyperparathyroidism of multiple endocrine neoplasia type I: Candidate gene and parathyroid calcium sensing protein expression. Surgery 118: 924-931.
7. Feinberg, A. P., and Vogelstein, B. (1983). A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 132: 6-13.
8. Fujimori, M., Wells, S. A., Jr., and Nakamura, Y. (1992). Fine-scale mapping of the gene responsible for multiple endocrine neoplasia, type 1. Am. J. Hum. Genet. 50: 399-403.
9. Gaudray, P., Szepetowski, P., Escot, C., Birnbaum, D., and Theillet, C. (1992). DNA amplification at 11q13 in human cancer: From complexity to perplexity. Mutat. Res. 276: 317-328.
10. Gerhard, D. S., Lawrence, E., Wu, J., Chua, H., Ma, N., Bland, S., and Jones, C. (1992). Isolation of 1001 new markers from human chromosome 11, excluding the region of 11p13-p15.5, and their sublocalization on a new set of radiation reduced somatic cell hybrids. Genomics 13: 1133-1142.
11. Grimmond, S., Weber, G., Larsson, C., Walters, M., Teh, B., Sheperd, J., Nordenskold, M., and Hayward, N. (1995). Exclusion of the 13-kDa rapamycin binding protein gene (FKBP2) as a candidate for multiple endocrine neoplasia type 1. Hum. Genet. 95: 455-458.
12. Kas, K., Weber, G., Merregaert, J., Michiels, L., Sandelin, K., Skogseid, B., Thompson, N., Nordenskjold, M., Larsson, C., and Friedman, E. (1993). Exclusion of Fau as the multiple endocrine neoplasia type 1 gene. Hum. Mol. Genet. 2: 349-353.
13. Knudsen, A. G. (1978). Retinoblastoma: A prototypic heriditary neoplasm. Semin. Oncol. 5: 57-60.
14. Knudsen, A. G. (1993). Anti-oncogenes and human cancer. Proc. Natl. Acad. Sci. USA 90: 10914-10921.
15. Lanahan, A. A., Williams, J. B., Sanders, L., and Nathans, D. (1992). Growth factor activated delayed-early response genes. Mol. Cell. Biol. 12: 3919-3929.
16. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y., and Nordenskjold, M. (1988). Multiple endocrine neoplasia syndrome type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332: 85-87.
17. Mullis, K. B., and Faloona, F. A. (1987). Specific synthesis of DNA in vitro via a polymerase catalyzed chain reaction. In "Methods in Enzymology" (R. Wu, Ed.), Vol. 155, pp. 335-350, Academic Press, New York.
18. Padgett, R. A., Grabowski, P. J., Konarska, M. M., Seiler, S., and Sharp, P. A. (1986). Splicing of messenger RNA precursors. Annu. Rev. Biochem. 55: 1119-1150.
19. Pang, J. T., and Thakker, R. V. (1994). Multiple endocrine neoplasia type 1 (MEN I). Eur. J. Cancer 30A: 1961-1968.
20. Pang, J. T., Lloyd, S. E., Woodling, C., Farren, B., Pottinger, B., Harding, B., Leigh, S. E. A., Pook, M. A., Benham, F. J., Gillet, G. T., Thomas Taggart, R., and Thakker, R. V. (1996). Genetic mapping studies of 40 loci and 23 cosmids chromosome 11p13-11q13, and exclusion of μ-calpain as the multiple endocrine neoplasia type 1 gene. Hum. Genet. 97: 732-741.
21. Pizzuti, A., Friedman, D. L., and Caskey, C. T. (1993). The myotonic dystrophy gene. Arch. Neurol. 50: 1173-1179.
22. Qin, S., Zhang, J., Isaacs, C. M., Nagafuchi, S., Jani Sait, S. N., Abel, K. J., Higgins, M. J., Nowak, N. J., and Shows, T. B. (1993). A chromosome 11 YAC library. Genomics 16: 580-585.
23. Radford, D. M., Ashley, S. W., Wells, S. A., Jr., and Gerhard, D. S. (1990). Loss of heterozygosity of markers on chromosome 11 in tumors from patients with multiple endocrine neoplasia syndrome type 1. Cancer Res. 50: 6529-6533.
24. Rochelle, J. M., Watson, M. L., Oakey, R. J., and Seldin, M. F. (1992). A linkage map of mouse chromosome 19: Definition of comparative mapping relationships with human chromosomes 10 and 11 including the MEN I locus. Genomics 14: 26-31.
25. Sanger, F., Nicklen, S., and Coulson, A. R. (1977). DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA 74: 5463-5467.
26. Schuuring, E. (1995). The involvement of the chromosome 11q13 region in human malignancies: Cyclin D1 and EMS1 are two new candidate oncogenes - A review. Gene 159: 83-96.
27. Smith, C. M., Wells, S. A., Jr., and Gerhard, D. S. (1995a). Mapping eight new polymorphisms in 11q13 in the vicinity of multiple endocrine neoplasia type 1: Identification of a new distal recombinant. Hum. Genet. 96: 377-387.
28. Smith, C. M., Bora, P. S., Bora, N. S., Jones, C., and Gerhard, D. S. (1995b). Genetic and radiation reduced somatic cell hybrid mapping of glutatione S-transferase, P1 gene. Cytogenet. Cell Genet. 71: 235-239.
29. Szepetowski, P., Perucca-Lostanlen, D., and Gaudray, P. (1993). Mapping genes according to their amplification status in tumor cells: Contribution to the map of 11q13. Genomics 16: 745-750.
30. Tanigami, A., Tokino, T., Takita, K., Ueda, M., Kasumi, F., and Nakamura, Y. (1992). Detailed analysis of an amplified region at chromosome 11q13 in malignant tumors. Genomics 13: 21-24.
31. Teh, B. T., Cardinal, J., Sheperd, J., Hayward, N. K., Weber, G., Cameron, D., and Larsson, C. (1995). Genetic mapping of the multiple endocrine neoplasia syndrome type 1 locus at 11q13. J. Int. Med. 238: 249-253.
32. Thakker, R.V., Bouloux, P., Wooding, C., Chotai, K., Borad, P.M., Spurr, N. K., Besser, G. M., and O'Riordan, J. L. (1989). Association of tumors in multiple endocrine neoplasia syndrome type 1 with loss of alleles on chromosome 11. N. Engl. J. Med. 321: 218-224.
33. Thakker, R. V., Wooding, C., Pang, J. T., Farren, B., Harding, B., Anderson, D. C., Besser, G. M., Bouloux, P., Brenton, D. P., Buchanan, K. D., Edwards, C. R., Heath, D. A., et al. (1993). Linkage analysis of 7 polymorphic markers at 11p11.2-11q13 in 27 multiple endocrine neoplasia type 1 families. Ann. Hum. Genet. 57: 17-25.
34. Toda, T., Iida, A., Miwa, T., Nakamura, Y., and Imai, T. (1994). Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1. Hum. Mol. Genet. 3: 465-470.
35. Trask, B. (1991). DNA sequence localization in metaphase and interphase cells by fluorescence in situ hybridization. In "Methods in Cell Biology" (B. A. Hankalo and S. C. R. Elgin, Eds.), Vol. 35, pp. 1-35, Academic Press, New York.
36. Weber, G., Friedman, E., Grimmond, S., Hayward, N. K., Phelan, C., Skogseid, B., Gobi, A., Zedenius, J., Sandelin, K., Teh, B. T., Carson, E., White, I., Oberg, K., Sheperd, J., Nordenskjold, M., and Larsson, C. (1994). The phospholipase C β3 gene located in the MEN 1 region shows loss of expression in endocrine tumors. Hum. Mol. Genet. 3: 1775-1781.
37. Williams, J. B., and Lanahan, A. A. (1995). A mammalian delayed-early response gene encodes HNP36, a novel, conserved nucleolar protein. Biochem. Biophys. Res. Commun. 213: 325-333.